SCHEMBL6680402

SCHEMBL6680402

CC[C@@]1(C(=O)O)CCC[C@@H]1N

nearest known ligand 0.42

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.33
ARG1 P05089 4/20 0.32
ARG2 P78540 2/20 0.32
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6215052 1.00 CYP1A2 (0.33) CYP1A2ARG1ARG2ALDH1A1
SCHEMBL3865460 1.00 CYP1A2 (0.33) CYP1A2ARG1ARG2ALDH1A1
Hydrochloric Acid SCHEMBL4235768 0.98 CYP1A2 (0.33) CYP1A2ARG1ARG2
Hydrochloric Acid SCHEMBL5898246 0.98 CYP1A2 (0.33) CYP1A2ARG1ARG2
Hydrochloric Acid SCHEMBL6218699 0.98 CYP1A2 (0.33) CYP1A2ARG1ARG2
SCHEMBL2124257 0.94 CYP2C19 (0.31)
SCHEMBL5321582 0.94 CYP2C19 (0.31)
SCHEMBL11611121 0.94 CYP2C19 (0.31)
Hydrochloric Acid SCHEMBL4260557 0.93 MEN1 (0.31)
SCHEMBL5322364 0.93 CYP2C19 (0.33) CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760878-B1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS BAYER IP GMBH (DE) 2015-10-28 EP disclosed
EP-1397137-A4 HYDANTION DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES BRISTOL MYERS SQUIBB CO (US) 2004-10-13 EP disclosed
EP-1397137-A1 HYDANTION DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES BRISTOL-MYERS SQUIBB COMPANY (US) 2004-03-17 EP disclosed
WO-2002096426-A1 HYDANTION DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-12-05 WO disclosed